Business Wire

Lineage Logistics Commits $5 Million and Launches Its “Share A Meal” Campaign to Help Provide 100 Million Meals in Response to COVID-19

23.3.2020 22:27:00 EET | Business Wire | Press release

Share

Lineage Logistics Holdings, LLC (“Lineage” or the “Company”), the world’s largest and most innovative provider of temperature-controlled logistics, today announced its commitment to a $5 million donation and the launch of its Share A Meal campaign to help provide 100 million meals* to people in need in response to COVID-19.

“The COVID-19 virus presents extraordinary challenges for moving, storing, and distributing food on a large scale,” said Greg Lehmkuhl, Lineage’s President & CEO. “At Lineage, we’ve built a business dedicated to shepherding food all over the world, which puts us in a unique position to help overcome these challenges. We want to do our part by sharing what we have to offer – including temperature-controlled warehouse space, supply chain logistics expertise and financial resources.”

In honor of this response and to kick off the campaign, Lineage is donating $1 million to the Feeding America® COVID-19 Response Fund and will donate up to $500,000 more to match contributions made to the fundraiser run by Stephen and Ayesha Curry's Eat. Learn. Play. Foundation, in which all funds are directed to Feeding America®, the nation’s largest domestic hunger-relief organization.

“We're working in a myriad of ways to ensure that every person in need, particularly the residents of Oakland, California, has access to the food they need during this COVID-19 crisis,” said Chris Helfrich, CEO of the Eat. Learn. Play. Foundation. “We're proud to be doing this work alongside Lineage Logistics – they’ve quickly established themselves as an invaluable partner in these critical times.”

“We are very proud to join forces and launch our Share A Meal campaign with Stephen and Ayesha Curry’s Eat. Learn. Play. Foundation to work with Feeding America and provide much-needed meals from coast to coast,” said Kevin Marchetti, Co-Executive Chairman of Lineage Logistics Holdings, LLC. “We hope to connect with inspirational changemakers like the Curry’s in communities across the United States and around the world in pursuit of our goal of helping to provide 100 million meals to people in need.”

In addition to these initial commitments, Lineage is looking to work closely with a number of other strategic partners to make financial and logistical contributions in communities worldwide and reach Share A Meal ’s ambitious goal.

Lineage will engage its expansive network of customers, which includes some of the world’s largest food producers and manufacturers, to join Lineage in its commitment, and the Company will challenge its investors, vendors and other likeminded leaders and businesses to donate as well as we work together to ensure people around the world have access to the feed they need. Additionally, recognizing that COVID-19 is a worldwide crisis, Lineage has engaged with the Global FoodBanking Network, to provide funds, donate food and volunteer the Company’s storage resources and distribution expertise on a global scale.

“We have the opportunity to rise to the occasion in a critical time of need and actively live out Lineage’s purpose statement of helping to feed the world,” Lehmkuhl said. “It’s a time to ask ourselves what we stand for, and how far we are willing to go in service of others. We are 14,000 strong in communities near and far. As citizens of the world, we are in this together, and we know Lineage can – and must – do more.”

*Lineage’s goal to help provide 100 million meals will include financial and in-kind donations facilitated by Lineage and its partners to Feeding America and other hunger-relief organizations. To support Lineage’s Share a Meal campaign and make a donation to Feeding America’s COVID-19 Response Fund, please visit: www.feedingamerica.org/lineage-covid

About Lineage Logistics

Lineage is the world’s largest and most innovative provider of temperature-controlled logistics solutions. Lineage’s expertise in end-to-end logistical solutions, its unrivaled facility network, and its use of technology combine to promote food safety, increase distribution efficiency, advance sustainability, lessen environmental impact, and minimize supply chain waste. As a result, Lineage helps customers ranging from Fortune 500 companies to small family-owned businesses increase the efficiency and protect the integrity of their temperature-controlled supply chain. In recognition of the company’s leading innovations, Lineage was recognized as the No 1. Data Science company on Fast Company’s Annual list of The World’s Most Innovative Companies in 2019, in addition to ranking 23rd overall in an evaluation of thousands of companies worldwide. For more information, visit: www.lineagelogistics.com.

About Feeding America®

Feeding America® is the largest hunger-relief organization in the United States. Through a network of 200 food banks and 60,000 food pantries and meal programs, we provide meals to more than 40 million people each year. Feeding America also supports programs that prevent food waste and improve food security among the people we serve; educates the public about the problem of hunger; and advocates for legislation that protects people from going hungry. Individuals, charities, businesses and government all have a role in ending hunger. Donate. Volunteer. Advocate. Educate. Together we can solve hunger. Visit www.feedingamerica.org, find us on Facebook or follow us on Twitter.

About The Global FoodBanking Network

The Global FoodBanking Network (GFN) is an international non-profit organization that nourishes the world’s hungry through uniting and advancing food banks in more than 30 countries. GFN focuses on combating hunger and preventing food waste by providing expertise, directing resources, sharing knowledge and developing connections that increase efficiency, ensure food safety and reach more people facing hunger. Last year, 943 GFN member food banks rescued over 500 million kilograms of food and grocery product and redirected it to feed 9.6 million people through a network of more than 55,000 social service and community-based organizations. For more information please visit www.foodbanking.org.

About Eat. Learn. Play.

Founded by three-time NBA champion and two-time MVP Stephen Curry and entrepreneur, host and The New York Times bestselling author Ayesha Curry, Eat. Learn. Play. Foundation seeks to unlock the human potential of every child. Focused on youth in underserved communities, the foundation's programs are anchored around three core values vital to a successful childhood: nutrition, education and physical activity. As emerging figures in the tech and food spaces, the Curry family is committed to increasing access to quality education for K-12 students, driving innovation and creativity and paving the way for bright futures. Eat. Learn. Play.'s education focus furthermore extends through college completion with a goal to close the graduation gap between low-income and minority students and their peers. The foundation's localized programs provide nutritious food for children in low-income neighborhoods to reduce childhood hunger, the tools to learn about holistic wellness and environments for safe play. In working with community partners across the country, Eat. Learn. Play. is committed to collaboratively improving lives for today's youth generation. To support Eat. Learn. Play.’s donations to the Alameda County Community Food Bank, please visit: bit.ly/elpcovidfund

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Megan Hendricksen
909.821.7692
mhendricksen@lineagelogistics.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye